Anterior
PrivateLast Round
Series B
Feb 12, 2026
Est. Valuation
$95M
Total Funding Raised
$63.2M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Anterior operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Series B round in February 2026.
Anterior is a healthcare technology company that provides an AI-powered clinical platform to automate administrative workflows for health plans.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, InsurTech, Workflow Automation, Healthcare Analytics, Revenue Cycle
Business Model
B2B
Customer Profile
Usage-Based SaaS, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Anterior Comparables
Compare Anterior with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Latitude Health | 88% | |
| Humata Health | 86% | |
| Banjo Health | 86% |
For institutional investors. Book with your work email.
Anterior Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Feb 12, 2026 | ||||
| Series A | Jun 10, 2024 | ||||
| Seed | Sep 17, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Anterior Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Anamcara Capital | Seed |
| Nebular Venture Capital | Seed |
| Neo | Seed, Series A |
| Ventures Together | Seed |
| Four Acres Capital | Seed |
| New Enterprise Associates | Series B, Series A |
| VT Partner LLC | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 1, 2026
Open roles increased to 37, representing 62% of headcount.
- Sep 1, 2026
Open roles increased to 37, 6.2x the trailing average.
For institutional investors. Book with your work email.
Anterior Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Anterior's valuation, stock price, and market status.
Is Anterior a public or private company?
Anterior is a private company.
What is the current stock price of Anterior?
Anterior is a private company, so its shares have no public market price. Caplight tracks Anterior's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Anterior worth (valuation)?
Anterior's valuation is estimated at $95.0M based on funding round data.
Can I buy Anterior stock?
Anterior shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Anterior's last funding round?
Anterior's most recent funding round was Series B on February 12, 2026.
Who are the main investors in Anterior?
Key investors in Anterior include New Enterprise Associates, Sequoia Capital.
Will Anterior IPO soon?
No public IPO plans have been announced for Anterior.
How can I track Anterior secondary market activity?
Caplight tracks bids, offers, and trades in Anterior's shares on secondary markets.